Medovate is an innovation development company dedicated to the commercialisation of pioneering medical technologies created within the NHS.

Backed with £9 million of investment capital, Medovate identifies and works with high potential medtech innovations. Medovate inject the specialist management resources and finance required to support innovation development through clinical trials and regulatory approval.

By providing funding and support at a crucial point in

the development of innovative medical technologies, Medovate accelerates innovations to market in order to benefit patient care and healthcare delivery.

For further information and to register for updates please visit the dedicated Medovate website.


Keep up to date with all HEE news and events.

We take your data very seriously, please read our privacy policy.